BioCentury
ARTICLE | Clinical News

MGI regulatory update

July 22, 1996 7:00 AM UTC

MOGN's Salagen Tablets received approval in Israel to treat the symptoms of xerostomia (dry mouth) caused by radiation therapy for cancer of the neck and head, and for the symptoms of Sjögren's Syndrome, an autoimmune disease. ...